Sunshine Act Hits Daylight Savings Time; PhRMA Seeks Extension For Physician Payment Reporting
Industry groups have asked HHS Secretary Kathleen Sebelius to give companies additional time to collect and report their payments to physicians and teaching hospitals since HHS has yet to establish the procedures for doing so.
You may also be interested in...
In its latest move on the transparency front, Glaxo endorses the U.K.-driven AllTrials campaign, which calls for releasing all clinical trial results. Announcement runs counter to PhRMA’s defense against requirements for more disclosure.
Physician Sunshine Rule Needs Longer Lead Time Before Implementation, PhRMA Says; Scope Challenged By CROs
The Pharmaceutical Research and Manufacturers of America seeks at least a six-month lead time before implementation in comments to CMS. The Association for Clinical Research Organizations takes issue with including payments for “legitimate” research in the rulemaking at all.
CMS postpones the deadline for drug makers to begin full implementation of the Sunshine Act until after it issues a final rule on how to collect the data. Current plans are to keep the March 31, 2013, deadline for companies to submit to HHS the data they do collect for 2012.